Navigation Links
Hormone Raises Desire for Fattening Foods
Date:6/22/2010

Study found ghrelin made people crave high-calorie food more

TUESDAY, June 22 (HealthDay News) -- You're dieting, and you know you should stay away from high-calorie snacks. Yet, your eyes keep straying toward that box of chocolates, and you wish there was a pill to restrain your impulse to inhale them.

Such a pill might one day be a real possibility, according to findings presented Tuesday at the Endocrine Society's annual meeting in San Diego. It would block the activity of ghrelin, the "hunger hormone" that stimulates the appetite centers of the brain.

The study, reported by Dr. Tony Goldstone, a consultant endocrinologist at the British Medical Research Council Clinical Sciences Center at Imperial College London, showed that ghrelin does raise the desire for high-calorie foods in humans.

"It's been known from animal and human work that ghrelin makes people hungrier," Goldstone said. "There has been a suspicion from animal work that it can also stimulate the rewards pathways of the brain and may be involved in the response to more rewarding foods, but we didn't have evidence of that in people."

The study that provided such evidence had 18 healthy adults look at pictures of different foods on three mornings, once after skipping breakfast and twice about 90 minutes after having breakfast. On one of the breakfast-eating mornings, all the participants got injections -- some of salt water, some of ghrelin. Then they looked at pictures of high-calorie foods such as chocolate, cake and pizza, and low-calorie foods such as salads and vegetables.

The participants used a keyboard to rate the appeal of those pictures. Low-calorie foods were rated about the same, no matter what was in the injections. But the high-calorie foods, especially sweets, rated higher in those who got ghrelin.

"It seems to alter the desire for high-calorie foods more than low-calorie foods," Goldstone said of ghrelin.

That effect was especially pronounced when the participants fasted overnight before the study was done. "We know that when you fast, you tend to crave high-calorie foods more," Goldstone said. "We mimicked that effect."

So a pill that blocked ghrelin's activity could be useful for dieters, and several drug companies already are working to develop one, he said. It wouldn't be something you could pop when a tempting dish appeared, because the blocking effect would take some time to happen, but it could be part of an overall weight-loss regimen, Goldstone said.

"If developed, it might have the particular effect of blocking the desire for high-calorie foods," he said.

The study results come as no surprise, said Alain Dagher, an associate professor of neurology at McGill University in Montreal, who has been studying ghrelin.

In his research, MRI scans of animals found that "ghrelin increases the brain response to food," Dagher said. "So, it's not surprising that a single injection in humans supports a shift to high-calorie foods in general."

Dagher is continuing his studies. "We've been trying to get more specific about exactly how ghrelin acts on the brain, which brain regions it affects and how those effects translate to eating," he said.

Ghrelin might not play a role in causing obesity, but it might act to keep people obese by reducing their ability to lose weight, Dagher said.

More information

To learn what ghrelin is and does, visit the University of Edinburgh.



SOURCES: Tony Goldstone, M.D., Ph.D, consultant endocrinologist, Medical Research Council Clinical Sciences Center, Imperial College London; Alain Dagher, Ph.D, associate professor, neurology, McGill University, Montreal; June 22, 2010, presentation, Endocrine Society annual meeting, San Diego


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Experts Issue Warning on Prostate Hormone Therapy
2. Stress Hormone Could Be Key to Alcoholism
3. Treating Low Growth Hormone in Childhood May Thwart Later Ills
4. More blood vessels in hormone-resistant prostate tumors
5. Fat Hormone May Protect Against Alzheimers
6. New human reproductive hormone could lead to novel contraceptives
7. Prostate Hormone Therapy May Up Heart Risks
8. Pioneering Hormone Therapist to Host Free Health Seminar
9. Hormone May Prevent Aggressive Breast Cancer
10. Bonding Hormone Might Help Some With Autism
11. WHI data confirm short-term heart disease risks of combination menopausal hormone therapy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormone Raises Desire for Fattening Foods
(Date:8/17/2017)... ... August 17, 2017 , ... An August 2 article ... obtaining plastic surgery, largely influenced by the growing popularity of “pretty boys” in both ... notes that standards of male appearance are changing not only in the Asian nation, ...
(Date:8/17/2017)... ... 2017 , ... Pot Valet is a leading provider of premium medical-grade cannabis ... state, and soon, every state in the country, the company offers patients safe, legal, ... altogether. , According to Pot Valet, all California patients have the legal ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... A recent ... to the biopharmaceutical industry in 2016 cited deficiencies in data integrity. The FDA outlines ... Part 11 ruling. , Presented as part of the Beckman Coulter Life ...
(Date:8/16/2017)... Los Angeles, California (PRWEB) , ... August 16, 2017 , ... An August 3rd ... patients that was the subject of a report in JAMA (the Journal of the American ... (BMIs) above 50 were able to achieve BMIs under 30, when compared to patients with ...
(Date:8/16/2017)... ... August 16, 2017 , ... For the second ... England student to educate the public on the impact of concussions. Brooke Mills, ... first-ever National Concussion Awareness Day. , Brooke is working diligently is to raise ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: ... quarter ended June 30, 2017, and updated its financial ... For the fiscal third quarter, Hill-Rom reported ... per diluted share in the prior-year period. These results ... per diluted share primarily related to the non-cash write-down ...
(Date:7/27/2017)... Pharmaceutical Services, Inc. (NYSE: WST ) today ... updated financial guidance for the full-year 2017. ... Reported net sales of $397.6 million, a record ... at constant currency (organic) grew by 3.9%. ... $0.60 in the prior-year quarter. Second-quarter 2017 adjusted diluted ...
(Date:7/26/2017)... July 26, 2017 Sancilio Pharmaceuticals Company, Inc. ... clinical trial evaluating Altemia TM , an oral therapy ... Sickle Cell Disease (SCD). The SCOT Trial, is a ... and safety of Altemia TM in pediatric patients ... US IND 125274. ...
Breaking Medicine Technology: